Cancer is the leading cause of death globally. The mission of the center is to identify novel therapeutic targets and develop new anti-cancer drugs using interdisciplinary, computational and biopharmaceutical technologies. Research areas covered in the center are broad, which include, but not limited to, cancer biology, immunology, pharmacology, pharmacodynamics, microbiology, gene & protein engineering, pharmacogenomics, biopharmaceuticals, cancer vaccines, gene therapy, drug safety evaluation and clinical trials, etc.
Immunotherapy for cancer and inflammatory diseases which include CAR-T,antibody, and RNA drug development
Molecular Mechanisms linking Inflammation and Cancer, and their implications for therapy
Cellular and Molecular Mechanisms of Autoimmune Diseases and their Therapy
Molecular Mechanisms Underlying Treg Cell Development and their Potential for Therapeutic Manipulation
Development of Novel Immunotherapeutic Strategies to Treat Chronic Diseases
Areas of Interest:Pathogenesis and treatment of cancer, inflammatory and autoimmune diseases.
Areas of Interest:1. Molecule mechanisms controlling the development, lineage stability and function of T cell subsets；2. Tumor immunology and immuno-therapy.
Areas of Interest:Epigenome mechanism of human growth and development, disease occurrence and development, and research and development of related epigenetic drugs
Areas of Interest:the role of autophagy in regulating tumor immunity